Cargando…
Tenascin-c mediated vasculogenic mimicry formation via regulation of MMP2/MMP9 in glioma
Vasculogenic mimicry (VM), the formation of vessel-like structures by highly invasive tumor cells, has been considered one of several mechanisms responsible for the failure of anti-angiogenesis therapy in glioma patients. Therefore, inhibiting VM formation might be an effective therapeutic method to...
Autores principales: | Cai, Hai-ping, Wang, Jing, Xi, Shao-yan, Ni, Xiang-rong, Chen, Yin-sheng, Yu, Yan-jiao, Cen, Zi-wen, Yu, Zhi-hui, Chen, Fu-rong, Guo, Cheng-cheng, Zhang, Ji, Ke, Chao, Wang, Jian, Chen, Zhong-ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6872754/ https://www.ncbi.nlm.nih.gov/pubmed/31754182 http://dx.doi.org/10.1038/s41419-019-2102-3 |
Ejemplares similares
-
MMP‐2 and MMP‐13 affect vasculogenic mimicry formation in large cell lung cancer
por: Li, Yanlei, et al.
Publicado: (2017) -
Clinical significance of vasculogenic mimicry in human gliomas
por: Liu, Xiao-mei, et al.
Publicado: (2011) -
Inhibitory effect of norcantharidin on melanoma tumor growth and vasculogenic mimicry by suppressing MMP-2 expression
por: Wang, Zhenyu, et al.
Publicado: (2017) -
Vasculogenic mimicry: a novel target for glioma therapy
por: Chen, Yin-Sheng, et al.
Publicado: (2014) -
Down‐regulating Myoferlin inhibits the vasculogenic mimicry of melanoma via decreasing MMP‐2 and inducing mesenchymal‐to‐epithelial transition
por: Zhang, Wenxue, et al.
Publicado: (2017)